ACADIAN ASSET MANAGEMENT LLC - IMPRIMIS PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 30 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of IMPRIMIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$878,000
+1413.8%
154,291
+637.3%
0.00%–
Q3 2018$58,000–20,926–0.00%–
 Download
Other shareholders

There were no reported owners of IMPRIMIS PHARMACEUTICALS INC in Q3 2018.

NameSharesValueWeighting ↓
View complete list of IMPRIMIS PHARMACEUTICALS INC shareholders